---
schema_version: "secwatch.filing_event.v1"
accession: "0001824293-25-000042"
form_type: "8-K"
ticker: "GRI"
cik: "0001824293"
company_name: "GRI Bio, Inc."
filed_at: "2025-02-19T23:59:59+00:00"
generated_at: "2026-05-26T12:23:50.822433+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# GRI Bio announces 1-for-17 reverse stock split effective Feb 21, 2025

## Summary
- Reverse split at 1:17 ratio, effective 4:01 p.m. ET on Feb 21, 2025; post-split trading begins Feb 24, 2025 on Nasdaq under symbol GRI.
- Outstanding shares will decrease from ~8.93 million to ~525,492; authorized share count unchanged.
- Reverse split is intended to regain compliance with Nasdaq minimum bid price requirement.
- Proportional adjustments will be made to exercise prices and shares for stock options, warrants, and convertible securities.
- No fractional shares issued; cash payment in lieu based on closing price on Feb 21, 2025.

## SEC filing metadata
- accession: 0001824293-25-000042
- form_type: 8-K
- ticker: GRI
- cik: 0001824293
- company_name: GRI Bio, Inc.
- filed_at: 2025-02-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.03, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1824293/000182429325000042/0001824293-25-000042-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1824293/000182429325000042/val-20250219.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001824293-25-000042
- JSON: https://secwatch.observer/filing/0001824293-25-000042.json
- Plain text: https://secwatch.observer/filing/0001824293-25-000042.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.